Long-term study finds modern hormone replacement therapy not linked to heart disease risk
A large-scale study of 52,000 women in Israel suggests that modern hormone replacement therapy (HRT) is not linked to an increased risk of heart disease or stroke. These findings support recent FDA decisions to remove warning labels from HRT products.
Why it matters
This research could significantly change medical guidance and improve the quality of life for women managing menopause symptoms.
edited by Swati Mestri , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Pixabay/CC0 Public Domain Contemporary hormone replacement therapy (HRT) was not associated with an increased risk of heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of more than 52,000 women in Israel. The findings from this independent, preliminary research will be presented at the American Heart Association's Scientific Sessions 2026 . The meeting is Nov. 6–9 in Chicago.
Also covering this story
2 other newsrooms covered this event. We read each version separately.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in